Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
XPOT pseudogene 3 (XPOTP3) is a presumed nonfunctional copy of the XPOT gene, which encodes a nuclear export receptor—exportin-t—responsible for exporting tRNAs from the nucleus to the cytoplasm in a Ran-GTP-dependent manner[1]. As a pseudogene, XPOTP3 lacks protein-coding potential and does not participate directly in cellular pathways, drug interaction mechanisms, or disease etiology. Pseudogenes are frequently considered genomic "fossils;" most have acquired disabling mutations and are not transcribed or translated, although in some cases pseudogenes can have regulatory roles as non-coding RNAs or through gene expression modulation[2][6]. There is no evidence currently linking XPOTP3 to any therapeutic function, disease, or biomarker context, and it is not considered a drug target. If you were searching for an active druggable target or protein-coding gene (such as XPOT itself), XPOTP3 is not appropriate—XPOT (Exportin-t) is the protein-coding parental gene that is functionally relevant[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on XPOT pseudogene 3 (XPOTP3).